Victims of a meningitis outbreak from tainted drugs would get at least $135 million in the proposed bankruptcy plan for the now defunct pharmaceutical company that made the steroid drugs.

New England Compounding Pharmacy Inc.’s tainted steroids are blamed for at least 64 deaths and 751 infections from fungal meningitis outbreaks starting in 2012.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]